The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Tamm-Horsfall Protein Binds to Type 1 Fimbriated Escherichia coli and Prevents E. coli from Binding to Uroplakin Ia and Ib Receptors
Open accessAbstract
The adherence of uropathogenic Escherichia coli to the urothelial surface, a critical first step in the pathogenesis of urinary tract infection (UTI), is controlled by three key elements: E. coli adhesins, host receptors, and host defense mechanisms. Although much has been learned about E. coli adhesins and their urothelial receptors, little is known about the role of host defense in the adherence process. Here we show that Tamm-Horsfall protein (THP) is the principal urinary protein that binds specifically to type 1 fimbriated E. coli, the main cause of UTI. The binding was highly specific and saturable and could be inhibited by d-mannose and abolished by endoglycosidase H treatment of THP, suggesting that the binding is mediated by the high-mannose moieties of THP. It is species-conserved, occurring in both human and mouse THPs. In addition, the binding to THP was much greater with an E. coli strain bearing a phenotypic variant of the type 1 fimbrial FimH adhesin characteristic of those prevalent in UTI isolates compared with the one prevalent in isolates from the large intestine of healthy individuals. Finally, a physiological concentration of THP completely abolished the binding of type 1 fimbriated E. coli to uroplakins Ia and Ib, two putative urothelial receptors for type 1 fimbriae. These results establish, on a functional level, that THP contains conserved high-mannose moieties capable of specific interaction with type 1 fimbriae and strongly suggest that this major urinary glycoprotein is a key urinary anti-adherence factor serving to prevent type 1 fimbriated E. coli from binding to the urothelial receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction and Evasion of Host Defenses by Type 1-Piliated Uropathogenic Escherichia coli
Mulvey, M. A., Lopez-Boado, Y. S., Wilson, C. L., Roth, R., Parks, W. C., Heuser, J., & Hultgren, S. J. (1998) · Science · doi:10.1126/science.282.5393.1494 · Cited by 947
Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.
Connell, I., Agace, W., Klemm, P., Schembri, M., Mărild, S., & Svanborg, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9827 · Cited by 735
Hull, R. A., Gill, R. E., Hsu, P., Minshew, B. H., & Falkow, S. (1981) · Infection and Immunity · doi:10.1128/iai.33.3.933-938.1981 · Cited by 588
Prevention of Mucosal Escherichia coli Infection by FimH-Adhesin-Based Systemic Vaccination
Langermann, S., Palaszynski, S., Barnhart, M., Auguste, G., Pinkner, J. S., Burlein, J., Barren, P., Koenig, S., Leath, S., Jones, C. H., et al. (1997) · Science · doi:10.1126/science.276.5312.607 · Cited by 577
THE MAMMALIAN URINARY BLADDERAN ACCOMMODATING ORGAN
HICKS, R. M. (1975) · Biological Reviews · doi:10.1111/j.1469-185x.1975.tb01057.x · Cited by 408
Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin
Sokurenko, E. V., Chesnokova, V., Dykhuizen, D. E., Ofek, I., Wu, X.-R., Krogfelt, K. A., Struve, C., Schembri, M. A., & Hasty, D. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8922 · Cited by 373
Self-citationThe cellular and molecular basis of gastric mucosal defense
Wallace, J. L., & Granger, D. N. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.7.8635690 · Cited by 347
Wu, X. R., Sun, T. T., & Medina, J. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9630 · Cited by 342
Self-citationStrömberg, N., Marklund, B. I., Lund, B., Ilver, D., Hamers, A., Gaastra, W., Karlsson, K. A., & Normark, S. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08328.x · Cited by 286
The Asn‐linked carbohydrate chains of human Tamm‐Horsfall glycoprotein of one male
Hård, K., van Zadelhoff, G., MOONEN, P., Kamerling, J. P., & Vliegenthart, J. F. G. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17362.x · Cited by 284
Tamm-Horsfall protein—uromodulin (1950–1990)
Kumar, S., & Muchmore, A. (1990) · Kidney International · doi:10.1038/ki.1990.128 · Cited by 256
THE FINE STRUCTURE OF THE TRANSITIONAL EPITHELIUM OF RAT URETER
Hicks, R. M. (1965) · The Journal of Cell Biology · doi:10.1083/jcb.26.1.25 · Cited by 241
O'Hanley, P., Lark, D., Falkow, S., & Schoolnik, G. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111707 · Cited by 224
Fu, D., Chen, L., & O'Neill, R. A. (1994) · Carbohydrate Research · doi:10.1016/0008-6215(94)84015-6 · Cited by 191
Yu, J., Lin, J., Wu, X., & Sun, T. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.125.1.171 · Cited by 186
Self-citationDiversity of the Escherichia coli Type 1 Fimbrial Lectin
Sokurenko, E. V., Chesnokova, V., Doyle, R. J., & Hasty, D. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17880 · Cited by 168
Self-citationUrinary Tract Infections: From Pathogenesis to Treatment
Stamm, W. E., Hooton, T. M., Johnson, J. R., Johnson, C., Stapleton, A., Roberts, P. L., Moseley, S. L., & Fihn, S. D. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.3.400 · Cited by 167
Mucus: The Front Line of Intestinal Mucosal Defense
LaMont, J. T. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb39760.x · Cited by 163
Sokurenko, E. V., Courtney, H. S., Ohman, D. E., Klemm, P., & Hasty, D. L. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.3.748-755.1994 · Cited by 160
Self-citationSokurenko, E. V., Courtney, H. S., Maslow, J. N., Siitonen, A., & Hasty, D. L. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.13.3680-3686.1995 · Cited by 155
Self-citationIdentification of factors in human urine that inhibit the binding of Escherichia coli adhesins
Parkkinen, J., Virkola, R., & Korhonen, T. K. (1988) · Infection and Immunity · doi:10.1128/iai.56.10.2623-2630.1988 · Cited by 138
Tamm–Horsfall urinary glycoprotein. The chemical composition
Fletcher, A. P., Neuberger, A., & RATCLIFFE, W. A. (1970) · Biochemical Journal · doi:10.1042/bj1200417 · Cited by 130
Wu, X., Medina, J. J., & Sun, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29752 · Cited by 127
Self-citationPATHOGENESIS OF URINARY TRACT INFECTION
Sobel, J. D. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70372-x · Cited by 112
Iwahi, T., Abe, Y., Nakao, M., Imada, A., & TSUCHIYA, K. (1983) · Infection and Immunity · doi:10.1128/iai.39.3.1307-1315.1983 · Cited by 109
Glycosylation sites and site-specific glycosylation in human Tamm-Horsfall glycoprotein
van Rooijen, J. J. M., Voskamp, A. F., Kamerling, J. P., & Vliegenthart, J. F. G. (1999) · Glycobiology · doi:10.1093/glycob/9.1.21 · Cited by 108
Lin, J., Wu, X., Kreibich, G., & Sun, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42095-3 · Cited by 105
Self-citationFunctional heterogeneity of type 1 fimbriae of Escherichia coli
Sokurenko, E. V., Courtney, H. S., Abraham, S. N., Klemm, P., & Hasty, D. L. (1992) · Infection and Immunity · doi:10.1128/iai.60.11.4709-4719.1992 · Cited by 93
Self-citationClegg, S. (1982) · Infection and Immunity · doi:10.1128/iai.38.2.739-744.1982 · Cited by 93
Keith, B. R., Maurer, L., Spears, P. A., & Orndorff, P. E. (1986) · Infection and Immunity · doi:10.1128/iai.53.3.693-696.1986 · Cited by 86
High-mannose oligosaccharides from human Tamm-Horsfall glycoprotein
Serafini‐Cessi, F., Dall’Olio, F., & Malagolini, N. (1984) · Bioscience Reports · doi:10.1007/bf01119663 · Cited by 53
Quantitation of Thmm-Horsfall Protein Binding to Uropathogenic Escherichia coli and Lectins
Reinhart, H. H., Obedeanu, N., & Sobel, J. D. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.6.1335 · Cited by 28
High-Mannose Chains of Mammalian Glycoproteins
Sherblom, A. P., & Smagula, R. M. (2003) · Humana Press eBooks · doi:10.1385/0-89603-226-4:143 · Cited by 10
Pathophysiology of Bacterial Cystitis
Roberts, J. A. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4737-2_25 · Cited by 7
Cited by
From carbohydrate leads to glycomimetic drugs
Ernst, B., & Magnani, J. L. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2852 · Cited by 820
Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium
Mabbott, N. A., Donaldson, D. S., Ohno, H., Williams, I. R., & Mahajan, A. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.30 · Cited by 721
“coli and may function to prevent these bacteria from binding to uroepithelial cells.(46) Although the expression of Umod by Peyer’s patch M cells is much lower than Gp2, their similar characteristics imply that each protein may aid the sampling of FimHþ bacteria in the gut lumen.”
BackgroundTerlizzi, M. E., Gribaudo, G., & Maffei, M. E. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01566 · Cited by 692
Barnich, N., Carvalho, F. A., Glasser, A.-L., Darcha, C., Jantscheff, P., Allez, M., Peeters, H., Bommelaer, G., Desreumaux, P., Colombel, J.-F., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30504 · Cited by 589
Anti-adhesion therapy of bacterial diseases: prospects and problems
Ofek, I., Hasty, D. L., & Sharon, N. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00228-1 · Cited by 444
Self-citation
Metadata
- Authors
- Pak, J., Pu, Y., Zhang, Z.-T., Hasty, D. L., & Wu, X.-R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 276
- Issue
- 13
- Pages
- 9924-9930
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2022548242
- Cited by
- 290
- References
- 34
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.